Kevin Shannon

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Tyrosine Kinase

Acute Lymphoblastic Leukemia

Top Venues

The Journal of experimental medicine

Cancer discovery

Nature chemical biology

This page only lists publications with an associated author ORCID identifier.

Publications

Elliot Stieglitz, Alex G Lee, Steven P Angus, Christopher Davis, Donald A Barkauskas, David C Hall, Scott C Kogan, Julia Meyer, Steven D Rhodes, Sarah K Tasian, Xiaoling Xuei, Kevin Shannon, Mignon L Loh, Elizabeth Fox, Brenda J Weigel
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group. Cancer discovery (2024)
Elliot Stieglitz, Alex G Lee, Steven P Angus, Christopher Davis, Donald A Barkauskas, David C Hall, Scott C Kogan, Julia Meyer, Steven D Rhodes, Sarah K Tasian, Xiaoling Xuei, Kevin Shannon, Mignon L Loh, Elizabeth Fox, Brenda J Weigel
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group. Cancer discovery (2024)
Elliot Stieglitz, Alex G Lee, Steven P Angus, Christopher Davis, Donald A Barkauskas, David C Hall, Scott C Kogan, Julia Meyer, Steven D Rhodes, Sarah K Tasian, Xiaoling Xuei, Kevin Shannon, Mignon L Loh, Elizabeth Fox, Brenda J Weigel
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group. Cancer discovery (2024)
Bogdan Popescu, Kevin Shannon
Sidestepping SHP2 inhibition. The Journal of experimental medicine 220 (5) (2023)
Bogdan Popescu, Kevin Shannon
Sidestepping SHP2 inhibition. The Journal of experimental medicine 220 (5) (2023)
Bogdan Popescu, Kevin Shannon
Sidestepping SHP2 inhibition. The Journal of experimental medicine 220 (5) (2023)
Bogdan Popescu, Kevin Shannon
Sidestepping SHP2 inhibition. The Journal of experimental medicine 220 (5) (2023)
Bogdan Popescu, Kevin Shannon
Sidestepping SHP2 inhibition. The Journal of experimental medicine 220 (5) (2023)
Julia Carnevale, Eric Shifrut, Nupura Kale, William A Nyberg, Franziska Blaeschke, Yan Yi Chen, Zhongmei Li, Sagar P Bapat, Morgan E Diolati, Patrick C O'Leary, Shane Vedova, Julia A Belk, Bence Daniel, Theodore L Roth, Stefanie Bachl, Alejandro Allo Anido, Brooke Prinzing, Jorge Ibañez-Vega, Shannon Lange, Dalia Haydar, Marie Luetke-Eversloh, Maelys Born-Bony, Bindu Hegde, Scott C Kogan, Tobias Feuchtinger, Hideho Okada, Ansuman T Satpathy, Kevin Shannon, Stephen Gottschalk, Justin Eyquem, Giedre Krenciute, Alan Ashworth, Alexander Marson
RASA2 ablation in T cells boosts antigen sensitivity and long-term function. Nature 609 (7925) (2022)
Jarrett R Remsberg, Radu M Suciu, Noemi A Zambetti, Thomas W Hanigan, Ari J Firestone, Anagha Inguva, Amanda Long, Nhi Ngo, Kenneth M Lum, Cassandra L Henry, Stewart K Richardson, Marina Predovic, Benjamin S Braun, Melissa M Dix, Amy R Howell, Micah J Niphakis, Kevin Shannon, Benjamin F Cravatt
ABHD17 regulation of plasma membrane palmitoylation and N-Ras-dependent cancer growth. Nature chemical biology 17 (8) (2021)
Benjamin S Braun, Anica M Wandler, Lauren K Meyer, Monique Dail, Anneleen Daemen, Deepak Sampath, Qing Li, Xinyue Wang, Jasmine C Wong, Joy Nakitandwe, James R Downing, Jinghui Zhang, Barry S Taylor, Kevin Shannon
Convergent genetic aberrations in murine and human T lineage acute lymphoblastic leukemias. PLoS genetics 15 (6) (2019)